News

Apellis Pharmaceuticals (APLS) Gets a Buy from Bank of America Securities
Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.
Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and LENZ Therapeutics (LENZ)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bristol-Myers Squibb (BMY – Research Report) and ...
Fierce Pharma3d
Apellis, AstraZeneca break down their #FierceMadness 2025 Drug Ad Tournament success
After several weeks and thousands of votes, TV drug ads from Apellis Pharmaceuticals and AstraZeneca found themselves in the final round of the annual #FierceMadness bracket competition. | After ...
RAPT Therapeutics Deepens Expertise in Allergic Diseases with Appointment of Jessica Savage, M.D., M.H.S., as Vice President, Clinical Development
RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...
BioHarvest Sciences Inc. (BHST) Soars 5.2%: Is Further Upside Left in the Stock?
BioHarvest Sciences Inc. (BHST) witnessed a jump in share price last session on above-average trading volume. The latest ...
Terns Pharmaceuticals (TERN) Gets a Buy from Mizuho Securities
Mizuho Securities analyst Graig Suvannavejh reiterated a Buy rating on Terns Pharmaceuticals (TERN – Research Report) today and set a price ...